Long non-coding RNA KCNQ1OT1 facilitates the progression of cervical cancer and tumor growth through modulating miR-296-5p/HYOU1 axis
暂无分享,去创建一个
[1] Shanshan Yang,et al. Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data , 2021, Frontiers in Cell and Developmental Biology.
[2] H. Nishi,et al. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. , 2021, Cancer biomarkers : section A of Disease markers.
[3] P. Zhou,et al. Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1 , 2021, Journal of immunology research.
[4] H. Zhang,et al. KCNQ1 opposite strand/antisense transcript 1 promotes aggressive biological behaviors of cervical cancer cells via regulating microRNA-491-5p and pyruvate kinase M1/2. , 2020, Journal of Biological Regulators and Homeostatic Agents.
[5] Y. Ai,et al. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2–IIIB cervical adenocarcinoma , 2020, Archives of Gynecology and Obstetrics.
[6] E. C. Coimbra,et al. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. , 2020, Critical reviews in oncology/hematology.
[7] G. Lou,et al. SP1‐induced lncRNA FOXD3‐AS1 contributes to tumorigenesis of cervical cancer by modulating the miR‐296‐5p/HMGA1 pathway , 2020, Journal of cellular biochemistry.
[8] Chun Qiu,et al. LncRNA MSC-AS1 facilitates lung adenocarcinoma through sponging miR-33b-5p to up-regulate GPAM. , 2020, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[9] Yili Liu,et al. LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1 , 2020, Cancer Gene Therapy.
[10] Lin Li,et al. LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149 , 2020, Cancer Gene Therapy.
[11] Kun Zhang,et al. Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] Xiang Yu,et al. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway , 2020, Oncology letters.
[13] Yan Wang,et al. LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer , 2020, Cancer Cell International.
[14] Young Seok Kim,et al. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy. , 2020, Gynecologic oncology.
[15] Ningjing Lei,et al. Long non-coding RNA DANCR promotes cervical cancer growth via activation of the Wnt/β-catenin signaling pathway , 2020, Cancer Cell International.
[16] F. Buonaguro,et al. The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer , 2020, Frontiers in Oncology.
[17] Xueyuan Liu,et al. Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR‐296‐5p/Bax axis , 2020, The FEBS journal.
[18] P. Benedetti Panici,et al. Targeting cervical cancer: Is there a role for poly (ADP‐ribose) polymerase inhibition? , 2020, Journal of cellular physiology.
[19] Weixin Zheng,et al. Long non-coding RNA SNHG3 accelerates progression in glioma by modulating miR-384/HDGF axis , 2020, Open life sciences.
[20] Y. Miao,et al. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway. , 2019, European review for medical and pharmacological sciences.
[21] H. Jin,et al. Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/β-catenin. , 2019, European Review for Medical and Pharmacological Sciences.
[22] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[23] Xiaodong Wang,et al. MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer , 2018, Oncology research.
[24] Xiaomeng Xia,et al. Wnt signaling in cervical cancer? , 2018, Journal of Cancer.
[25] Lei Xu,et al. LncRNA KCNQ1OT1 promotes osteogenic differentiation to relieve osteolysis via Wnt/β-catenin activation , 2018, Cell & Bioscience.
[26] O. Sheils,et al. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma. , 2017, Human pathology.
[27] A. Avan,et al. Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer , 2017, Journal of cellular biochemistry.
[28] Zhuo-wei Hu,et al. The regulation of β-catenin activity and function in cancer: therapeutic opportunities , 2017, Oncotarget.
[29] Z. Zeng,et al. HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis , 2016, Journal of Cancer.
[30] M. Frumovitz,et al. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma , 2015, Expert review of anticancer therapy.
[31] J. Berumen,et al. Targeting CDKN3 in cervical cancer , 2014, Expert opinion on therapeutic targets.
[32] M. B. Major,et al. Modulation of Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Function by Hypoxia-Upregulated Protein 1 , 2014, Journal of Virology.
[33] A. Stojadinovic,et al. HYOU1/Orp150 expression in breast cancer. , 2007, Medical science monitor : international medical journal of experimental and clinical research.
[34] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[35] Xiaohong Yu,et al. MiR-145 inhibits cervical cancer progression and metastasis by targeting WNT2B by Wnt/β-catenin pathway. , 2019, International journal of clinical and experimental pathology.
[36] X. Li,et al. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis. , 2019, European review for medical and pharmacological sciences.